These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9602950)

  • 1. Pharmacokinetics and pharmacodynamics of ranitidine in neonates treated with extracorporeal membrane oxygenation.
    Wells TG; Heulitt MJ; Taylor BJ; Fasules JW; Kearns GL
    J Clin Pharmacol; 1998 May; 38(5):402-7. PubMed ID: 9602950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of ranitidine in critically ill children.
    Lugo RA; Harrison AM; Cash J; Sweeley J; Vernon DD
    Crit Care Med; 2001 Apr; 29(4):759-64. PubMed ID: 11373465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
    Madani S; Kauffman R; Simpson P; Lehr VT; Lai ML; Sarniak A; Tolia V
    J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of ranitidine in renal impairment.
    Koch KM; Liu M; Davis IM; Shaw S; Yin Y
    Eur J Clin Pharmacol; 1997; 52(3):229-34. PubMed ID: 9218931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic modeling of the acid inhibitory effect of ranitidine in patients in an intensive care unit during prolonged dosing: characterization of tolerance.
    Mathôt RA; Geus WP
    Clin Pharmacol Ther; 1999 Aug; 66(2):140-51. PubMed ID: 10460068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of ranitidine after burn injury.
    Martyn JA; Bishop AL; Oliveri MF
    Clin Pharmacol Ther; 1992 Apr; 51(4):408-14. PubMed ID: 1563210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of gastric pH and guaiac measurements in neonates receiving acid suppression therapy during extracorporeal membrane oxygenation.
    Crill CM; Bugnitz MC; Hak EB
    Pharmacotherapy; 2004 Sep; 24(9):1130-6. PubMed ID: 15460173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. A comparison of relative efficacy and cost.
    Ballesteros MA; Hogan DL; Koss MA; Isenberg JI
    Ann Intern Med; 1990 Mar; 112(5):334-9. PubMed ID: 2306061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration.
    Lachman L; Howden CW
    Am J Gastroenterol; 2000 Jan; 95(1):57-61. PubMed ID: 10638559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intragastric pH and pharmacokinetics of intravenous ranitidine during sinusoidal and constant-rate infusions.
    Sanders SW; Bishop AL; Moore JG
    Chronobiol Int; 1991; 8(4):267-76. PubMed ID: 1797416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of oral ranitidine in children and adolescents with cystic fibrosis.
    James LP; Stowe CD; Farrar HC; Menendez AA; Argao EA
    J Clin Pharmacol; 1999 Dec; 39(12):1242-7. PubMed ID: 10586389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H; Böttcher MF; Ochmann K
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of famotidine in children.
    James LP; Marshall JD; Heulitt MJ; Wells TG; Letzig L; Kearns GL
    J Clin Pharmacol; 1996 Jan; 36(1):48-54. PubMed ID: 8932543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ranitidine on intragastric pH in clinically normal neonatal foals.
    Sanchez LC; Lester GD; Merritt AM
    J Am Vet Med Assoc; 1998 May; 212(9):1407-12. PubMed ID: 9589127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of famotidine in infants.
    James LP; Marotti T; Stowe CD; Farrar HC; Taylor BJ; Kearns GL
    J Clin Pharmacol; 1998 Dec; 38(12):1089-95. PubMed ID: 11301560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled comparison of continuous ranitidine and intermittent famotidine infusions on gastric pH.
    Bachmann K; Sullivan TJ; Jauregui L
    J Clin Pharmacol; 1993 Dec; 33(12):1219-24. PubMed ID: 7907348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of bismuth and ranitidine following multiple doses of ranitidine bismuth citrate.
    Koch KM; Kerr BM; Gooding AE; Davis IM
    Br J Clin Pharmacol; 1996 Aug; 42(2):207-11. PubMed ID: 8864319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Food but not a chemically defined diet interferes with maintenance of intragastric pH at a predefined level using continuous pH-stat-adjusted intravenous infusion of ranitidine in healthy volunteers.
    Thomson AB; Kirdeikis P; Lastiwka R; Zuk L; Jen M; Elias M; Johnston P
    Dig Dis Sci; 1999 Sep; 44(9):1858-64. PubMed ID: 10505726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of ranitidine and nizatidine in very elderly patients.
    Sasaki M; Sudoh T; Fujimura A
    Am J Ther; 2005; 12(3):223-5. PubMed ID: 15891265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine.
    Kletzl H; Giraudon M; Ducray PS; Abt M; Hamilton M; Lum BL
    Anticancer Drugs; 2015 Jun; 26(5):565-72. PubMed ID: 25643050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.